ursodiol disulfate (Axcan/CHRF)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameursodiol disulfate (Axcan/CHRF)
Drug Alias NameSUDCA (Axcan/CHRF)ursodiol sulfate (Axcan/CHRF)
ClassificationSmall molecules
Mechanisms of ActionBile acid modulators
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationPrecancerous ConditionsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCincinnati Children'S Hospital Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAptalis Pharma
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationPrecancerous ConditionsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A